Intuitive Surgical, Inc. (ISRG)
Up 950% Over the Past Decade, This Hot Stock Just Saw Its Revenue Soar. Is It Still a Buy?
Over the past decade, Intuitive Surgical (ISRG -0.58%) has proven to be a long-term winner in the healthcare sector. The stock is up more than 950% in that time frame, and more than 60% over the past year.
Is ISRG a Buy After Logging Robust System Placements in Q4?
Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The stock has also gained during the past month.
Buy, Sell, Or Hold ISRG Stock At $585?
Intuitive Surgical (NASDAQ: ISRG) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $2.4 billion and adjusted earnings of $2.21 per share, compared to the consensus estimates of $2.2 billion and $1.79, respectively.
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Prediction: This Company Will Have a Trillion-Dollar Market Cap by 2040
The list of companies with market caps of $1 trillion or more remains extremely short. However, there's little doubt that more companies will join this elite group over the coming decades.
Intuitive Surgical Drops After Earnings Beat. Wall Street Is Still Optimistic.
The company reported a fourth-quarter earnings and sales beat, but guidance left much to be desired.
Why Intuitive Surgical Stock Was Pulling Back Today
Shares of Intuitive Surgical (ISRG -3.67%) were pulling back today as a strong fourth-quarter earnings report didn't seem to be enough to justify the medical device maker's lofty valuation. Its guidance for 2025 was also slightly below estimates, which can often trigger a sell-off for growth stocks.
These Analysts Boost Their Forecasts On Intuitive Surgical Following Strong Q4 Results
Intuitive Surgical Inc ISRG reported better-than-expected financial results for the fourth quarter after the market close on Thursday.
ISRG Stock Falls Despite Q4 Earnings Beat & Robust Procedures
ISRG's fourth-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales.
3 Buy-and-Hold Stocks for Long-Term Growth
When it comes to looking for "buy-and-hold forever” stocks, there are some important things to pay attention to. The most notable is the ability of these companies to benefit from trends that are likely to remain important over long periods of time.
Intuitive Surgical, Inc. (ISRG) Q4 2024 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q4 2024 Earnings Conference Call January 23, 2025 4:30 PM ET Company Participants Brandon Lamm - IR Gary Guthart - CEO Jamie Samath - CFO Daniel Oh - Senior Medical Officer Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Travis Steed - Bank of America Securities Rick Wise - Stifel David Roman - Goldman Sachs Patrick Wood - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Q4 2024 Intuitive Earnings Conference Call.
Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
